BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kim M, Kizilbash SH, Laramy JK, Gampa G, Parrish KE, Sarkaria JN, Elmquist WF. Barriers to Effective Drug Treatment for Brain Metastases: A Multifactorial Problem in the Delivery of Precision Medicine. Pharm Res 2018;35:177. [PMID: 30003344 DOI: 10.1007/s11095-018-2455-9] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 5.5] [Reference Citation Analysis]
Number Citing Articles
1 Zhang Y, Zou Z, Liu S, Miao S, Liu H. Nanogels as Novel Nanocarrier Systems for Efficient Delivery of CNS Therapeutics. Front Bioeng Biotechnol 2022;10:954470. [DOI: 10.3389/fbioe.2022.954470] [Reference Citation Analysis]
2 Zhang Z, Xu M, Sakandar A, Du X, He H, He W, Li D, Wen Q. Successful Treatment of a Patient With Brain Metastasis From Ovarian Cancer With BRCA Wild Type Using Niraparib: A Case Report and Review of the Literature. Front Oncol 2022;12:873198. [DOI: 10.3389/fonc.2022.873198] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Perng P, Lai Y, Lee P, Huang C, Hsu H, Lee J. Safety and Efficacy of Sorafenib and Lenvatinib in Patients Who Underwent Surgery or Whole-Brain Radiotherapy for Brain Metastasis of Hepatocellular Carcinoma. JCM 2022;11:1536. [DOI: 10.3390/jcm11061536] [Reference Citation Analysis]
4 Wang Q, Liu J. Medulloblastoma: Immune microenvironment and targeted nano-therapy. OpenNano 2022;6:100035. [DOI: 10.1016/j.onano.2022.100035] [Reference Citation Analysis]
5 Choi PJ, Cooper EA, Park TI, Denny WA, Jose J. Novel synthetic approach for accessing drug–dye conjugates for targeted tumour therapy. Results in Chemistry 2022;4:100343. [DOI: 10.1016/j.rechem.2022.100343] [Reference Citation Analysis]
6 Parakh S, Nicolazzo J, Scott AM, Gan HK. Antibody Drug Conjugates in Glioblastoma - Is There a Future for Them? Front Oncol 2021;11:718590. [PMID: 34926242 DOI: 10.3389/fonc.2021.718590] [Reference Citation Analysis]
7 Robey RW, Robinson AN, Ali-Rahmani F, Huff LM, Lusvarghi S, Vahedi S, Hotz JM, Warner AC, Butcher D, Matta J, Edmondson EF, Lee TD, Roth JS, Lee OW, Shen M, Tanner K, Hall MD, Ambudkar SV, Gottesman MM. Characterization and tissue localization of zebrafish homologs of the human ABCB1 multidrug transporter. Sci Rep 2021;11:24150. [PMID: 34921178 DOI: 10.1038/s41598-021-03500-8] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Blethen KE, Arsiwala TA, Fladeland RA, Sprowls SA, Panchal DM, Adkins CE, Kielkowski BN, Earp LE, Glass MJ, Pritt TA, Cabuyao YM, Aulakh S, Lockman PR. Modulation of the blood-tumor barrier to enhance drug delivery and efficacy for brain metastases. Neurooncol Adv 2021;3:v133-43. [PMID: 34859240 DOI: 10.1093/noajnl/vdab123] [Reference Citation Analysis]
9 Mo F, Pellerino A, Soffietti R, Rudà R. Blood-Brain Barrier in Brain Tumors: Biology and Clinical Relevance. Int J Mol Sci 2021;22:12654. [PMID: 34884457 DOI: 10.3390/ijms222312654] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 7.0] [Reference Citation Analysis]
10 Ratnam NM, Sonnemann HM, Frederico SC, Chen H, Hutchinson MND, Dowdy T, Reid CM, Jung J, Zhang W, Song H, Zhang M, Davis D, Larion M, Giles AJ, Gilbert MR. Reversing Epigenetic Gene Silencing to Overcome Immune Evasion in CNS Malignancies. Front Oncol 2021;11:719091. [PMID: 34336705 DOI: 10.3389/fonc.2021.719091] [Reference Citation Analysis]
11 Kalita B, Coumar MS. Deciphering molecular mechanisms of metastasis: novel insights into targets and therapeutics. Cell Oncol (Dordr) 2021;44:751-75. [PMID: 33914273 DOI: 10.1007/s13402-021-00611-2] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Augustine R, Aqel AH, Kalva SN, Joshy KS, Nayeem A, Hasan A. Bioengineered microfluidic blood-brain barrier models in oncology research. Transl Oncol 2021;14:101087. [PMID: 33865030 DOI: 10.1016/j.tranon.2021.101087] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
13 Kizilbash SH, Gupta SK, Parrish KE, Laramy JK, Kim M, Gampa G, Carlson BL, Bakken KK, Mladek AC, Schroeder MA, Decker PA, Elmquist WF, Sarkaria JN. In Vivo Efficacy of Tesevatinib in EGFR-Amplified Patient-Derived Xenograft Glioblastoma Models May Be Limited by Tissue Binding and Compensatory Signaling. Mol Cancer Ther 2021;20:1009-18. [PMID: 33785646 DOI: 10.1158/1535-7163.MCT-20-0640] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 de Gooijer MC, Kemper EM, Buil LCM, Çitirikkaya CH, Buckle T, Beijnen JH, van Tellingen O. ATP-binding cassette transporters restrict drug delivery and efficacy against brain tumors even when blood-brain barrier integrity is lost. Cell Rep Med 2021;2:100184. [PMID: 33521698 DOI: 10.1016/j.xcrm.2020.100184] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
15 Ma Z, Lu S, Zhou H, Zhang S, Wang Y, Lin N. Determination of intracellular anlotinib, osimertinib, afatinib and gefitinib accumulations in human brain microvascular endothelial cells by liquid chromatography/tandem mass spectrometry. Rapid Commun Mass Spectrom 2021;35:e8955. [PMID: 32990383 DOI: 10.1002/rcm.8955] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Tomasini P, Barlesi F, Gilles S, Nanni-Metellus I, Soffietti R, Denicolai E, Pellegrino E, Bialecki E, Ouafik L, Metellus P. Comparative genomic analysis of primary tumors and paired brain metastases in lung cancer patients by whole exome sequencing: a pilot study. Oncotarget 2020;11:4648-54. [PMID: 33400739 DOI: 10.18632/oncotarget.27837] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
17 Longuespée R, Theile D, Fresnais M, Burhenne J, Weiss J, Haefeli WE. Approaching sites of action of drugs in clinical pharmacology: New analytical options and their challenges. Br J Clin Pharmacol 2021;87:858-74. [PMID: 32881012 DOI: 10.1111/bcp.14543] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
18 Soffietti R, Ahluwalia M, Lin N, Rudà R. Management of brain metastases according to molecular subtypes. Nat Rev Neurol 2020;16:557-74. [PMID: 32873927 DOI: 10.1038/s41582-020-0391-x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 10.5] [Reference Citation Analysis]
19 Borella F, Bertero L, Morrone A, Gambella A, Bovetti M, Cosma S, Carosso A, Katsaros D, Gemmiti S, Preti M, Valabrega G, Scotto G, Cassoni P, Benedetto C. Brain Metastases from Ovarian Cancer: Current Evidence in Diagnosis, Treatment, and Prognosis. Cancers (Basel) 2020;12:E2156. [PMID: 32759682 DOI: 10.3390/cancers12082156] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
20 Soffietti R, Pellerino A, Rudà R. Strategies to prevent brain metastasis. Curr Opin Oncol 2019;31:493-500. [PMID: 31414987 DOI: 10.1097/CCO.0000000000000572] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
21 Rudà R, Soffietti R. Does an optimal management of brain metastases from oncogenic-driver non-small cell lung cancer exist? Neuro Oncol 2020;22:171-2. [PMID: 31858130 DOI: 10.1093/neuonc/noz238] [Reference Citation Analysis]
22 Kim M, Laramy JK, Gampa G, Parrish KE, Brundage R, Sarkaria JN, Elmquist WF. Brain Distributional Kinetics of a Novel MDM2 Inhibitor SAR405838: Implications for Use in Brain Tumor Therapy. Drug Metab Dispos 2019;47:1403-14. [PMID: 31619389 DOI: 10.1124/dmd.119.088716] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
23 Arvanitis CD, Ferraro GB, Jain RK. The blood-brain barrier and blood-tumour barrier in brain tumours and metastases. Nat Rev Cancer 2020;20:26-41. [PMID: 31601988 DOI: 10.1038/s41568-019-0205-x] [Cited by in Crossref: 212] [Cited by in F6Publishing: 192] [Article Influence: 70.7] [Reference Citation Analysis]
24 Kasten BB, Udayakumar N, Leavenworth JW, Wu AM, Lapi SE, McConathy JE, Sorace AG, Bag AK, Markert JM, Warram JM. Current and Future Imaging Methods for Evaluating Response to Immunotherapy in Neuro-Oncology. Theranostics 2019;9:5085-104. [PMID: 31410203 DOI: 10.7150/thno.34415] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 6.0] [Reference Citation Analysis]
25 Pellerino A, Buffoni L, Rudà R, Soffietti R. Complete response of spinal metastases from non-small cell lung cancer with ALK inhibitors. Neurology 2019;93:217-9. [PMID: 31248938 DOI: 10.1212/WNL.0000000000007866] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
26 Hu Y, Hammarlund-Udenaes M, Fridén M. Understanding the Influence of Nanocarrier-Mediated Brain Delivery on Therapeutic Performance Through Pharmacokinetic-Pharmacodynamic Modeling. J Pharm Sci 2019;108:3425-33. [PMID: 31163187 DOI: 10.1016/j.xphs.2019.05.029] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
27 van Bussel MTJ, Beijnen JH, Brandsma D. Intracranial antitumor responses of nivolumab and ipilimumab: a pharmacodynamic and pharmacokinetic perspective, a scoping systematic review. BMC Cancer 2019;19:519. [PMID: 31146733 DOI: 10.1186/s12885-019-5741-y] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 4.7] [Reference Citation Analysis]
28 Poloyac SM, Bertz RJ, McDermott LA, Marathe P. Pharmacological Optimization for Successful Traumatic Brain Injury Drug Development. J Neurotrauma 2020;37:2435-44. [PMID: 30816062 DOI: 10.1089/neu.2018.6295] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
29 Gampa G, Kim M, Mohammad AS, Parrish KE, Mladek AC, Sarkaria JN, Elmquist WF. Brain Distribution and Active Efflux of Three panRAF Inhibitors: Considerations in the Treatment of Melanoma Brain Metastases. J Pharmacol Exp Ther 2019;368:446-61. [PMID: 30622172 DOI: 10.1124/jpet.118.253708] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]